IMPLAVAX
LIVE

Serial Number

79233134

Owner

Enesi Pharma Limited

Attorney

Rebecca A. Liebowitz

Filing Date

Mar 20, 2018

Add to watchlist:

No watchlists yet
View on USPTO

IMPLAVAX Trademark

Serial Number: 79233134 • Registration: 5706102

IMPLAVAX is a trademark filed by Enesi Pharma Limited on March 20, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Enesi Pharma Limited (3 trademarks)

120 A&B Olympic Avenue,

Entity Type: 99

Trademark Details

Filing Date

March 20, 2018

Registration Date

March 26, 2019

Published for Opposition

January 8, 2019

Cancellation Date

October 10, 2025

Goods & Services

Pharmaceutical and veterinary preparations and substances for the treatment of and protection against infectious and autoimmune diseases; pharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substances against infectious and autoimmune diseases; vaccines, prophylactic vaccines, therapeutic vaccines; contraceptive preparations and substances

Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery systems for delivery of drugs and vaccines; needle-free drug delivery systems sold empty; actuator devices, namely, medical solid dose injectors sold empty for injecting pharmaceutical and veterinary preparations into the skin; drug cassettes in the nature of drug and vaccine delivery systems sold empty; medical needle-free injection systems, needle-free injectors, namely, injection devices for administering drugs and vaccines sold empty; drug delivery injection devices for administering drugs and vaccines, namely, medical injectors, needle-free injectors and structural parts therefor sold empty; actuator devices for use in drug delivery devices, namely, handheld spring-powered devices in the nature of needle-free injection systems for injecting pharmaceutical and veterinary preparations into the skin sold empty; drug cassettes for use in drug delivery devices in the nature of drug and vaccine delivery systems sold empty to contain pharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use; replacement parts for all the aforesaid goods

Filing History

CANCELLED SECTION 71
Oct 10, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 26, 2024 REM3
COUNTERCLAIM OPP. NO. 999999
Jun 4, 2020 CCON
NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Jan 3, 2020 C.7C
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 9, 2019 APRE
TEAS SECTION 7 REQUEST RECEIVED
Nov 5, 2019 ES7R
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 3, 2019 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 16, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 30, 2019 FICS
FINAL DISPOSITION PROCESSED
Jul 30, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 26, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 26, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 8, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 8, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 19, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 31, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 3, 2018 GNFN
FINAL REFUSAL E-MAILED
Oct 3, 2018 GNFR
FINAL REFUSAL WRITTEN
Oct 3, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 25, 2018 TROA
REFUSAL PROCESSED BY IB
Jul 27, 2018 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 12, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jul 12, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 3, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jul 2, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 29, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 12, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 31, 2018 REPR